FSDKSH reimbursement fraud: fictitious pharmaceutical inventories through a depot (Tirana, 2025)
Status: Pretrial measures ordered (November 2025). Trial status not found in sources reviewed.
Summary
In November 2025 the Tirana prosecution placed a former director of the Health Insurance Fund (FSDKSH), Spartak Zekja, in pretrial detention, and took measures against several others, including FSDKSH employees and the administrator of a pharmaceutical depot. The prosecution alleges that the depot and two linked entities used fictitious inventories and invoices to claim FSDKSH reimbursement funds, valued at more than EUR 700,000 by the headline figure.
According to the report, medicines named in the allegations were supposedly sold through the system to other pharmacies, but were never bought or physically present. Prosecutors allege that Zekja signed a contract with one of the entities while he was director, involving forged documents, and that three fund employees did not physically check the declared medicines. The case started after a complaint from an exclusive licensed importer.
The depot administrator was ordered detained but listed as wanted. Other measures included obligations to appear, suspension from duty, and exit bans. No defence statements are reported in the sources reviewed.
Key facts
- Eight measures reported in total, including pretrial detention of the former FSDKSH director.
- Charges reported: document forgery and concealment of income.
- Declared inventories of 10 million and 60 million new lekë (as reported) for the two linked entities.
- The depot administrator was listed as wanted, not arrested, at the time of the report.
The record
Four lists kept apart on purpose: what is established, what is only alleged, what is still open, and what those concerned said.
What is proven (1)
Established by documents or official records, as stated in the research. A recorded charge or indictment proves only that the accusation was made.
- The measures were ordered by the prosecution, as reported. Pretrial measures are not a verdict.
What is alleged (1)
Accusations, not findings. Those accused are presumed innocent.
- AllegationThat medicines named in the scheme were never purchased or physically present while being billed through FSDKSH reimbursement.
Allegations and who made them (2)
Each line is an allegation as recorded, with the person or body that made it where the record names them.
- AllegationProsecutors allege fictitious inventories and invoices were used to claim FSDKSH reimbursement (Shqiptarja, 2025-11-04).
- AllegationProsecutors allege a contract signed by the former director with one linked entity involved forged documents.
Open questions (3)
- Was the former director's contract with the entity a public procurement or a private arrangement?
- Did the fund's own controls and the three employees' checks follow the procedures?
- Is there a trial date?
Responses (1)
Responses of the people and organisations concerned, as recorded.
- No defence or response from the suspects is reported in the sources reviewed (Shqiptarja, 2025-11-04).
Figures
Money trail →Alleged fictitious medicine inventories claimed for reimbursement
€700,000
Stated definition: Headline figure ('over 700,000 euros in medicines') as reported. Alleged claims, not payments confirmed by a court.
Date: 4 Nov 2025 · Payer: FSDKSH · Payee: Depot and two linked entities (as alleged)
- Fraud scheme for drug reimbursement: head of FSDKSH arrested (opens in a new tab)Shqiptarja.com · 4 Nov 2025 · journalism · SQ
Timeline
Full timeline →Police
Former FSDKSH director detained over fictitious medicine inventories
The Tirana prosecution ordered pretrial detention for the former FSDKSH director and other measures for FSDKSH employees and a depot administrator, over allegedly fictitious medicine inventories billed for reimbursement.
Hypotheses
Possible explanations that connect this record with other findings. They are not findings; each lists the evidence for and against.
- Source label: Unverified
FSDKSH controls failed in several ways at once: fictitious reimbursement, unperformed check-ups and unpunished oncology delays
The depot case alleges fictitious inventories billed to FSDKSH (Nov 2025). Vetting (Mar 2026) reports a Check-Up concession paying a fixed fee for about 475,000 checks while about 467,000 were performed in 2023, 49 documented cancer-drug delays since 2020 with about 49 million lekë penalties never collected, and ten directors in ten years. The common thread is weak verification before payment.
Evidence for
- Prosecution alleges fictitious inventories and invoices claimed as reimbursement, and that three fund employees did not physically check medicines (Shqiptarja, 2025).
- Vetting reports the fixed-fee Check-Up payment regardless of volume and weak contract monitoring (Vetting, 2026).
- Vetting reports 49 cancer-drug delays and penalties not collected.
Evidence against
- The depot case is an allegation under prosecution review; no verdict exists.
- The Check-Up and oncology problems are documented by Vetting and by an earlier KLSH finding, but no SPAK charge on them was found; these are separate matters that may not share a cause.
- Turnover of directors may reflect political change, not a single control failure.
Sources for this record
Every source the research cites for this record, grouped by its source label. 1 source.
Source label: Officially reportedOfficially reported · 1 source
- Publisher
- Shqiptarja.com
- Date
- 4 Nov 2025